Viking Therapeutics (NASDAQ:VKTX) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Viking Therapeutics (VKTX) operate in?

Viking Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Viking Therapeutics Stock (NASDAQ: VKTX) stock price, news, charts, stock research, profile.

Open	$30.53
Close	$29.26
Volume / Avg.	2.45M / 3.87M
Day Range	$29.25 - $30.70
52 Wk Range	28.64 - 99.41
Market Cap	$3.28B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	34
Short Interest	28.84%
Days to Cover	6.26

Recent News

This GE Vernova Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Avi Kapoor

Viking Therapeutics Shares Drop After Q4 EPS Miss Estimates

Viking Therapeutics announces its fourth-quarter financial results after Wednesday's closing bell. Here's a look at the details from the report.

Erica Kollmann

Jim Cramer: This Industrial Stock Is 'Absolutely Terrific', First Solar Is 'Very Inexpensive'

First Solar will report financial results for the fourth quarter and full year ended Dec. 31, 2024, after the closing bell on Tuesday, Feb. 25, 2025.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Dec 24

Jan

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$30.53
Close	$29.26
Volume / Avg.	2.45M / 3.87M
Day Range	$29.25 - $30.70
52 Wk Range	28.64 - 99.41
Market Cap	$3.28B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	34
Short Interest	28.84%
Days to Cover	6.26

About Viking Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of bio...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Viking Therapeutics (VKTX) stock?

You can purchase shares of Viking Therapeutics (NASDAQ:VKTX) through any online brokerage.

View our list of the best stock brokerages

Who are Viking Therapeutics (VKTX) competitors?

Other companies in Viking Therapeutics’s space includes: Immunovant (NASDAQ:IMVT), Twist Bioscience (NASDAQ:TWST), Ultragenyx Pharmaceutical (NASDAQ:RARE), Avidity Biosciences (NASDAQ:RNA) and MoonLake (NASDAQ:MLTX).

What is the forecast, or price target, for Viking Therapeutics (VKTX) stock?

Viking Therapeutics has a consensus price target of $77.58.

What is the current price for Viking Therapeutics (VKTX)?

The stock price for Viking Therapeutics (NASDAQ: VKTX) is $29.45 last updated February 18, 2025 at 4:29 PM EST.

Does Viking Therapeutics (VKTX) pay a dividend?

There are no upcoming dividends for Viking Therapeutics.

When is Viking Therapeutics (NASDAQ:VKTX) reporting earnings?

Viking Therapeutics’s Q1 earnings are confirmed for Wednesday, April 23, 2025.

Is Viking Therapeutics (VKTX) going to split?

There is no upcoming split for Viking Therapeutics.

What sector and industry does Viking Therapeutics (VKTX) operate in?

Viking Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Viking Therapeutics

Viking Therapeutics (VKTX) Forecast